A double blind randomized trial of wound infiltration with ropivacaine after breast cancer surgery with axillary nodes dissection

Axelle Vigneau, Anne Salengro, Joelle Berger, Roman Rouzier, Emmanuel Barranger, Emmanuel Marret, Francis Bonnet, Axelle Vigneau, Anne Salengro, Joelle Berger, Roman Rouzier, Emmanuel Barranger, Emmanuel Marret, Francis Bonnet

Abstract

Background: The effect of local infiltration after breast surgery is controversial. This prospective double blind randomized study sought to document the analgesic effect of local anaesthetic infiltration after breast cancer surgery.

Methods: Patients scheduled for mastectomy or tumorectomy and axillary nodes dissection had immediate postoperative infiltration of the surgical wound with 20 ml of ropivacaine 7.5 mg.ml-1 or isotonic saline. Pain was assessed on a visual analogue scale at H2, H4, H6, H12, H24, H72, and at 2 month, at rest and on mobilization of the arm. Patient'comfort was evaluated with numerical 0-3 scales for fatigue, quality of sleep, state of mood, social function and activity.

Results: Twenty-two and 24 patients were included in the ropivacaine and saline groups respectively. Postoperative pain was lower at rest and on mobilization at 2, 4 and 6 hour after surgery in the ropivacaine group. No other difference in pain intensity and patient 'comfort scoring was documented during the first 3 postoperative days. Patients did not differ at 2 month for pain and comfort scores.

Conclusion: Single shot infiltration with ropivacaine transiently improves postoperative pain control after breast cancer surgery.

Trial registration number: NCT01404377.

Figures

Figure 1
Figure 1
VAS scores on mobilization of the arm on the operated side in the two groups of patients in the postoperative period and at two month. * P < 0.05.
Figure 2
Figure 2
VAS scores at rest in the two groups of patients in the postoperative period and at two month. * p < 0.05.
Figure 3
Figure 3
Values of abduction angle of the arm in the postoperative period and at two month in the control and the ropivacaine groups.

References

    1. Scott NB. Wound infiltration for surgery. Anaesthesia. 2010;65S:67–75.
    1. Moiniche S, Mikkelsen S, Wetterslev J, Dahl JB. A systematic review of incisional local anaesthesia for postoperative pain after abdominal operations. Brit J Anaesth. 1998;81:377–83.
    1. Tasmuth T, von Smitten K, Hietanen P, Kataja M, Kalso E. Pain and other symptoms after different treatment modalities of breast cancer. Ann Oncol. 1995;6:453–9.
    1. Gärtner R, Jensen MB, Nielsen J, Ewertz M, Kroman N, Kehlet H. Preevalence of and factors associated with persistent pain following breast cancer surgery. JAMA. 2009;302:1985–92. doi: 10.1001/jama.2009.1568.
    1. Marret E, Vigneau A, Salengro A, Noirot A, Bonnet F. Effectiveness of analgesic techniques after breast surgery: a meta-analysis. Ann Fr Anesth Réanim. 2006;25:947–54.
    1. Pettersson N, Perbeck L, Hahn RG. Efficacy of subcutaneous and topical anaesthesia for pain relief after resection of malignant breast tumours. Eur J Surg. 2001;167:825–30. doi: 10.1080/11024150152717652.
    1. Baudry G, Steghens A, Laplaza D, Koeberle P, Bachour K, Bettinger G, Combier F, Samain E. Ropivacaine infiltration during breast cancer surgery. Ann Fr Anesth Reanim. 2008;27:979–86. doi: 10.1016/j.annfar.2008.10.006.
    1. Rosaeg OP, Bell M, Cicutti NJ, Dennehy KC, Lui AC, Krepski B. Preincision infiltration with lidocaine reduces pain an opioid consumption after reduction mammoplasty. Reg Anesth PainMed. 1998;23:575–9.
    1. Sidiropoulou T, Buonomo O, Fabbi E, Silvi MB, Kostopanagiotou G, Sabato AF, Dauri M. A prospective comparison of continuous wound infiltration with ropivacaine versus single-injection paravertebral block after modified radical mastectomy. Anesth Analg. 2008;106:997–1001. doi: 10.1213/ane.0b013e31816152da.
    1. Schell SR. Patients outcomes after axillary lymph node dissection for breast cancer: use of postoperative continuous local anesthesia infusion. J Surg Research. 2006;134:124–32. doi: 10.1016/j.jss.2005.11.571.
    1. Gomez-Hernandez J, Orozco-Alatorre AL, Dominguez-Contreras M, Gomez-Romo S, Villasenor ASA, Fuentes-Orozco C, Gonzales-Ojeda A. Preoperative dexamethasone reduces postoperative pain, nausea, and vomiting following mastectomy for cancer. BMC Cancer. 2010;10:692. doi: 10.1186/1471-2407-10-692.
    1. Fassoulaki A, Sarantopoulos C, Melemeni A, Hogan Q. Regional block and mexilitine: the effect on pain after cancer breast surgery. Reg Anesth Pain Med. 2001;26:223–8.
    1. Fassoulaki A, Sarantopoulos C, Melemeni A, Hogan Q. EMLA reduces acute and chronic pain after breast surgery for cancer. Reg Anesth Pain Med. 2000;25:350–55.
    1. Boughey JC, Goranvanchi F, Parris RN, Kee SS, Frenzel JC, Hunt KK, Ames FC, Kuerer H, Lucci A. Improved postoperative pain control using thoracic paravertebral block for breast operations. The Breast Journal. 2009;15:483–88. doi: 10.1111/j.1524-4741.2009.00763.x.
    1. Moller JF, Nikolajsen L, Rodt SA, Carlsson PS. Thoracic paravertebral block for breast cancer surgery. A randomized double-blind study. Anesth Analg. 2007;105:1848–51. doi: 10.1213/01.ane.0000286135.21333.fd.
    1. Boughey JC, Goranvanchi F, Parris RN, Kee SS, Kowalsi AM, Frenzel JC, Bedrosian I, Meric-Bernstamm F, Hunt KK, Ames FC, Kuerer HM, Lucci A. Prospective randomized trial of paravertebral block for patients undergoing breast cancer surgery. Am J Surg. 2009;198:720–5. doi: 10.1016/j.amjsurg.2008.11.043.
    1. Thavanerswaran P, Rudkin GE, Cooter RD, Moyese DG, Perera CL, Maddern GJ. Paravertebral block for anesthesia: a systematic review Anesth Analg. 2010. pp. 1740–4.
    1. O'Hanlon DM, Colbert ST, Keane PW, Given FH. Preemptive bupivacaine offers no advantages to postoperative wound infiltration in analgesia for outpatient breast biopsy. Am J Surg. 2000;180:29–32. doi: 10.1016/S0002-9610(00)00413-X.
    1. Ip HY, Abrishami A, Peng PW, Wong J, Chung F. Predictors of postoperative pain and analgesic consumption: a qualitative systematic review. Anesthesiology. 2009;111:657–77. doi: 10.1097/ALN.0b013e3181aae87a.

Source: PubMed

3
Předplatit